Rating History for Genmab A/S (GMAB) by Leerink

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/5/2026 Asthika Goonewardene New Coverage Outperform
(N/A)
50.00
(N/A)
34.75
(37.00)
6.47% Details